Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1HU6

SOLUTION STRUCTURE OF G10 NOVISPIRIN

Summary for 1HU6
Entry DOI10.2210/pdb1hu6/pdb
NMR InformationBMRB: 5034
DescriptorG10 NOVISPIRIN (1 entity in total)
Functional Keywordssolution structure, unknown function
Total number of polymer chains1
Total formula weight2214.79
Authors
Sawai, M.V.,Waring, A.J.,Kearney, W.R.,McCray Jr., P.B.,Forsyth, W.R.,Lehrer, R.I.,Tack, B.F. (deposition date: 2001-01-04, release date: 2002-04-05, Last modification date: 2024-05-22)
Primary citationSawai, M.V.,Waring, A.J.,Kearney, W.R.,McCray Jr., P.B.,Forsyth, W.R.,Lehrer, R.I.,Tack, B.F.
Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides.
Protein Eng., 15:225-232, 2002
Cited by
PubMed Abstract: We studied three model antibacterial peptides that resembled the N-terminal 18 amino acids of SMAP-29, an alpha-helical, antimicrobial peptide of sheep. Although the parent compound, ovispirin-1 (KNLRR IIRKI IHIIK KYG), was potently antimicrobial, it was also highly cytotoxic to human epithelial cells and hemolytic for human erythrocytes. Single residue substitutions to ovispirin-1 yielded two substantially less cytotoxic peptides (novispirins), with intact antimicrobial properties. One of these, novispirin G-10, differed from ovispirin-1 only by containing glycine at position 10, instead of isoleucine. The other, novispirin T-7, contained threonine instead of isoleucine at position 7. We determined the three-dimensional solution structures of all three peptides by circular dichroism spectroscopy and two-dimensional nuclear magnetic resonance spectroscopy. Although all retained an amphipathic helical structure in 2,2,2-trifluoroethanol, they manifested subtle fine-structural changes that evidently impacted their activities greatly. These findings show that simple structural modifications can 'fine-tune' an antimicrobial peptide to minimize unwanted cytotoxicity while retaining its desired activity.
PubMed: 11932493
DOI: 10.1093/protein/15.3.225
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon